Controlling Differentiation of Stem Cells for Developing Personalized Organ-on-Chip Platforms

Area of Science:

• Biomedical Engineering
• Stem Cell Biology
• Drug Discovery

Background:

• Organ-on-chip (OOC) platforms are crucial for pharmaceutical research.
• Traditional OOCs utilize cell lines or primary cells.
• Human stem cells offer advantages due to self-renewal and differentiation capabilities.

Purpose of the Study:

• To review stem cell applications in OOC technology.
• To discuss various tissue- and organ-on-chip platforms.
• To highlight challenges and future directions for stem cell-based OOCs.

Main Methods:

• Microfluidic control of stem cell differentiation via soluble factors, biophysical cues, and electromagnetic signals.
• Development of biomimetic tissue models using human stem cells.
• Review of OOC design, fabrication, and performance.

Main Results:

• Stem cells are critical for synthesizing complex tissues in OOCs.
• Various OOC platforms (skin, brain, liver, etc.) incorporating stem cells are discussed.
• Improved functionality and high-throughput performance of stem cell-based OOCs are noted.

Conclusions:

• Stem cell-based OOCs represent a significant advancement in drug screening and development.
• Overcoming technical challenges is key to realizing the full potential of these platforms.
• Future perspectives indicate continued innovation in stem cell-driven OOC research.